NO965276L - Benzoylekgonin-, ekgonin- og ekgonindinderivater - Google Patents

Benzoylekgonin-, ekgonin- og ekgonindinderivater

Info

Publication number
NO965276L
NO965276L NO965276A NO965276A NO965276L NO 965276 L NO965276 L NO 965276L NO 965276 A NO965276 A NO 965276A NO 965276 A NO965276 A NO 965276A NO 965276 L NO965276 L NO 965276L
Authority
NO
Norway
Prior art keywords
ecgonine
disorders
derivatives
ecgonindine
benzoyl
Prior art date
Application number
NO965276A
Other languages
English (en)
Norwegian (no)
Other versions
NO965276D0 (no
Inventor
James E Wynn
Lowell M Somers
Original Assignee
Entropin Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Entropin Inc filed Critical Entropin Inc
Publication of NO965276L publication Critical patent/NO965276L/no
Publication of NO965276D0 publication Critical patent/NO965276D0/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
    • C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
    • C07D451/04—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof with hetero atoms directly attached in position 3 of the 8-azabicyclo [3.2.1] octane or in position 7 of the 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring system
    • C07D451/06—Oxygen atoms
    • C07D451/12—Oxygen atoms acylated by aromatic or heteroaromatic carboxylic acids, e.g. cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
    • A61P5/40—Mineralocorticosteroids, e.g. aldosterone; Drugs increasing or potentiating the activity of mineralocorticosteroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Immunology (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Rheumatology (AREA)
  • Diabetes (AREA)
  • Pulmonology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Non-Portable Lighting Devices Or Systems Thereof (AREA)
  • Materials For Medical Uses (AREA)
NO965276A 1994-06-16 1996-12-10 Benzoylekgonin-, ekgonin- og ekgonindinderivater NO965276D0 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/260,054 US5525613A (en) 1994-06-16 1994-06-16 Covalently coupled benzoylecgonine ecgonine and ecgonidine
PCT/US1995/007268 WO1995034561A1 (en) 1994-06-16 1995-06-07 Benzoylecgonine, ecgonine and ecgonidine derivatives

Publications (2)

Publication Number Publication Date
NO965276L true NO965276L (no) 1996-12-10
NO965276D0 NO965276D0 (no) 1996-12-10

Family

ID=22987610

Family Applications (1)

Application Number Title Priority Date Filing Date
NO965276A NO965276D0 (no) 1994-06-16 1996-12-10 Benzoylekgonin-, ekgonin- og ekgonindinderivater

Country Status (21)

Country Link
US (1) US5525613A (zh)
EP (2) EP0765326B1 (zh)
JP (1) JP2951409B2 (zh)
KR (1) KR100407458B1 (zh)
CN (1) CN1046511C (zh)
AT (1) ATE255108T1 (zh)
AU (1) AU693571B2 (zh)
CA (1) CA2190611A1 (zh)
DE (1) DE69532203T2 (zh)
DK (1) DK0765326T3 (zh)
ES (1) ES2210296T3 (zh)
HK (1) HK1012626A1 (zh)
HU (1) HU224634B1 (zh)
IL (1) IL114177A (zh)
MX (1) MX9606374A (zh)
NO (1) NO965276D0 (zh)
NZ (1) NZ288844A (zh)
PL (1) PL186000B1 (zh)
PT (1) PT765326E (zh)
WO (1) WO1995034561A1 (zh)
ZA (1) ZA955002B (zh)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6270766B1 (en) * 1992-10-08 2001-08-07 The Kennedy Institute Of Rheumatology Anti-TNF antibodies and methotrexate in the treatment of arthritis and crohn's disease
US5763456A (en) * 1995-06-07 1998-06-09 Entropin, Inc. Benzoylecgonine, ecgonine and ecgonidine derivatives
US6482831B1 (en) 1994-06-16 2002-11-19 Entropin, Inc. Covalently coupled benzoylecgonine, egconine and ecgonidine derivatives
US6103698A (en) 1997-03-13 2000-08-15 Basf Aktiengesellschaft Dolastatin-15 derivatives in combination with taxanes
WO2003042209A1 (en) 2001-11-13 2003-05-22 Entropin, Inc. Novel benzoylecgonine compositions and methods for producing them
WO2004052888A2 (en) * 2002-12-05 2004-06-24 Entropin, Inc. Tropane esters and methods for producing and using them
AR060358A1 (es) * 2006-04-06 2008-06-11 Novartis Vaccines & Diagnostic Quinazolinas para la inhibicion de pdk 1
EP2431368B1 (en) 2006-05-19 2014-08-27 AbbVie Bahamas Ltd. CNS active fused bicycloheterocycle substituted azabicyclic alkane derivatives

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2893996A (en) * 1957-10-14 1959-07-07 Grace W R & Co N-amino derivatives of tropine alkaloids
US2948730A (en) * 1959-02-04 1960-08-09 Grace W R & Co 8-aminotropanium compounds
US4469700A (en) * 1981-06-19 1984-09-04 Lowell M. Somers Benzoylecgonine or benzoylnorecgonine as active agents for the treatment of rheumatoid arthritis
US4512996A (en) * 1982-12-13 1985-04-23 Lowell Somers Benzoylecgonine or benzoylnorecgonine as active agents for the treatment of rheumatoid arthritis
US4556663A (en) * 1982-12-13 1985-12-03 Somers Lowell M Benzoylecgonine, benzoylnorecgonine and ecgonine as active agents for the treatment of rheumatoid arthritis and osteoarthritis
FR2569563B1 (fr) * 1984-09-03 1987-07-03 Somers Lowell Formulation a base de benzoylecgonine ou de benzoylnorecgonine pour le traitement du rhumatisme articulaire
US5376667A (en) * 1992-12-31 1994-12-27 Entropin, Inc. Derivatives of benzoylecgonine, ecgonine and their multiple pharmacological properties

Also Published As

Publication number Publication date
JPH09510991A (ja) 1997-11-04
HUT75869A (en) 1997-05-28
EP1466913A1 (en) 2004-10-13
AU2820095A (en) 1996-01-05
CN1150802A (zh) 1997-05-28
ATE255108T1 (de) 2003-12-15
EP0765326A1 (en) 1997-04-02
KR100407458B1 (ko) 2004-03-26
HK1012626A1 (en) 1999-08-06
HU9603443D0 (en) 1997-02-28
MX9606374A (es) 1997-03-29
WO1995034561A1 (en) 1995-12-21
DE69532203D1 (de) 2004-01-08
CN1046511C (zh) 1999-11-17
IL114177A (en) 2000-02-17
DE69532203T2 (de) 2004-09-09
ZA955002B (en) 1996-02-08
PL186000B1 (pl) 2003-09-30
EP0765326B1 (en) 2003-11-26
ES2210296T3 (es) 2004-07-01
HU224634B1 (hu) 2005-12-28
DK0765326T3 (da) 2004-04-05
NZ288844A (en) 1998-05-27
PL317754A1 (en) 1997-04-28
JP2951409B2 (ja) 1999-09-20
NO965276D0 (no) 1996-12-10
IL114177A0 (en) 1995-10-31
PT765326E (pt) 2004-03-31
US5525613A (en) 1996-06-11
AU693571B2 (en) 1998-07-02
CA2190611A1 (en) 1995-12-21

Similar Documents

Publication Publication Date Title
MY130145A (en) Quinuclidine derivative for treatment of inflammatory and gastrointestinal disorders.
EP0703785B8 (en) Methods for treating muscle diseases and disorders
DE69512925T2 (de) Ortho-substituierte aromatische ether und ihre verwendung in schmerzstillenden pharmazeutischen zusammensetzungen
AU2911489A (en) Quinoline derivatives as antagonists of leukotriene d4
BR9506819A (pt) Derivados de ácido micofenólico substituídos na posiçao 5
FI954130A0 (fi) Heterosykliset yhdisteet ja niiden valmistus ja käyttö
EP0378086A3 (de) Verwendung des Wirkstoffs Azelastin zur Bekämpfung von Psoriasis-Erkrankungen
NO965276D0 (no) Benzoylekgonin-, ekgonin- og ekgonindinderivater
GR3006815T3 (zh)
CA2143610A1 (en) Use of norastemizole for the treatment of allergic disorders
IL108193A0 (en) Benzoylecgonine, ecgonine and ecgonidine derivatives, pharmaceutical compositions containing the same, and methods for the preparation therof
EE04040B1 (et) Aminotetraliini derivaat kardiovaskulaarsete haiguste raviks
WO2004052888A3 (en) Tropane esters and methods for producing and using them
DE69722816D1 (de) Neue derivate von benzoylalkyl-1,2,3,6-tetrahydropyridinen
DK72790D0 (da) Heterocycliske forbindelser, deres fremstilling og anvendelse

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application